Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at the Milken Institute Global Conference to discuss the impact of AI and machine learning on cancer medicine, including:

  • Mike Nohaile, Senior Vice President of Strategy, Commercialization and Innovation, Amgen
  • Maurice Ferré, CEO and Chairman of the Board, INSIGHTEC
  • Susan Swetter, Professor of Dermatology and Director of the Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute

See the full conversation below!